Furthermore, the EGFR-MET interaction induced by transforming growth factor-α, a specific EGFR ligand, overexpression and concomitant phosphorylation of MET, and activation of MET downstream effectors have been proposed to be closely associated with the acquired resistance to cetuximab in CRC cells [51,52]. Here, EGFR is linked to colorectal carcinoma.